AACC American Association for Clinical Chemistry
Avatar

Evaluation of Sex-Specific 99th Percentile URLs for hs-cTn Assays: Will the Use of 99th Percentile URLs Influence the Detection Rates of Myocardial Injury and Infarction? What Are the Sex-Specific 99th Percentiles Variations?

By AACC American Association for Clinical Chemistry FEATURING Fred S. Apple
October 7, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Baptist Health South Florida CME

Primary Care Focus Symposium Online

Wed, Jul 28, 2021
Cedars Sinai

15th Annual Women and Ischemic Heart Disease Symposium

Fri, Apr 23, 2021
Houston Methodist DeBakey Heart and Vascular Center

5th Annual Cardiology for the Non-Cardiologist

Sat, May 22, 2021
MUSC Cardiology

Charleston HFpEF Virtual Conference: The Latest Knowledge on Heart Failure…

Fri, Apr 16, 2021
Inova Cherry Blossom Virtual Cardiovascular Symposium 2021

Inova Cherry Blossom Virtual Cardiovascular Symposium 2021

Fri, Apr 23, 2021
CSI Education

CSI Focus D-HF: The Future of Device Based Therapies and Diagnostics for H…

Fri, Apr 23, 2021
27:33
Boston Scientific

Multi-Sensor Heart Failure Monitoring: What Are the Benefits of HeartLogic…

Feat. J. Boehmer
14:46
Boston Scientific

Predicting Heart Failure Events in Patients with Implanted Devices: How Su…

Feat. J. Boehmer
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

19:39
Boston Scientific

HRS Science: How Precise Are Novel Heart Failure Sensors for Predicting He…

Feat. K. Stein, A. Seiler
24:58
Boston Scientific

How to Manage HF using a Remote Heart Failure Diagnostic and Monitoring So…

Feat. J. Boehmer
25:31
Novartis

The War on Heart Failure

Feat. E. Braunwald
47:43
Medtronic

My Patient's Short-Term Cardiac Monitor Delivered - How to Transition to R…

05:10
Boston Scientific

HeartLogic™: The First FDA-Approved Predictive Analytic Alert in an Implan…

Feat. A. Hernandez, J. Boehmer, J. Singh, C. Fier, N. Albert
25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
18:35
Heart Failure 2021: An Update on Therapy

SGLT2 Inhibitors for HF: What Is the Effect of Empagliflozin on Cardiovasc…

Feat. M. Packer
64:40
Cardiac Contractility Modulation

CCM® Therapy - Mechanism of Action, Patient Selection and Identification

Feat. A. Kaplan, H. Saltzman
16:54
Cardiac Contractility Modulation

Cardiac Contractility Modulation: How it Works

Feat. J. Ehrlich, H. Levin
61:12
Cardiac Contractility Modulation

Assessing Heart Failure Patients - Where Does CCM® Therapy Fit

Feat. S. Brune, N. Bonnet, M. Arnold
21:21
Heart Failure 2021: An Update on Therapy

Biomarkers in Heart Failure: What Do the ACC Guidelines Say About the Use …

Feat. J. Januzzi
33:38
Cardiac Contractility Modulation

AAHFN Advanced 2020 - CCM® in HF - Mechanism and Clinical Evidence

Feat. R. Kahwash, N. Albert
63:10
Cardiac Contractility Modulation

Failure Is not an Option! Implementing CCM into your Practice

Feat. F. Syed, M. Goldschmidt, I. Rao
88:01
Cardiac Contractility Modulation

The Comparison and Advantages of the Use of Device Therapy in Heart Failur…

Feat. V. Thohan, G. Tomassoni, R. Doshi, F. Abi-Samra, I. Rao
13:01
Innovations in Cardiac Rhythm Management

Watchman Implantation: Tips and Tricks

Feat. S. Doshi
21:28
Keck School of Medicine of USC

Takotsubo Syndrome: What Diagnostic Criteria Are Available? Which Drugs to…

Feat. H. Van Herle
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhib…

Feat. B. Greenberg